Development of 3′-Deoxy-3′,4′-didehydro-nucleoside Prodrug Inhibitors of West Nile and Zika Viruses

Samantha A. Kennelly, Jacob M. Sawyer, Anne F. Payne, Alexander T. Ciota, Daniel A. Harki

Research output: Contribution to journalArticlepeer-review

Abstract

The antiviral enzyme viperin catalyzes the formation of 3′-deoxy-3′,4′-didehydro-cytidine-5′-triphosphate (ddhCTP). ddhCTP is incorporated into viral genomes and terminates genomic replication to confer broad-spectrum antiviral effects. We have previously utilized phosphoramidate pronucleotide (ProTide) technology to enable metabolic production of ddhCTP in cells from an exogenously dosed 3′-deoxy-3′,4′-didehydro-cytidine ProTide, which confers inhibitory activity against West Nile virus (WNV) and Zika virus (ZIKV). Herein, we synthesized 3′-deoxy-3′,4′-didehydro-nucleosides containing all native nucleobases (thymine, uracil, adenine, guanine, and hypoxanthine), elaborated each to a ProTide, and measured their activity for controlling WNV and ZIKV infection. In comparison to the ddhC ProTide, we found that the ProTides of 3′-deoxy-3′,4′-didehydro-guanosine and 3′-deoxy-3′,4′-didehydro-adenosine possess 2- and 4-fold greater antiviral effects against ZIKV, respectively. Collectively, this work advances the development of 3′-deoxy-3′,4′-didehydro nucleosides as promising compounds for further development into broad-spectrum antiviral agents.

Original languageEnglish (US)
Pages (from-to)1334-1339
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume15
Issue number8
DOIs
StatePublished - Aug 8 2024

Bibliographical note

Publisher Copyright:
© 2024 American Chemical Society.

Keywords

  • 3′-Deoxy-3′,4′-didehydro-nucleosides
  • Antiviral Agents
  • Nucleosides
  • Prodrugs
  • West Nile Virus
  • Zika Virus

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Development of 3′-Deoxy-3′,4′-didehydro-nucleoside Prodrug Inhibitors of West Nile and Zika Viruses'. Together they form a unique fingerprint.

Cite this